Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

1.

Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014.

Post F, Gori T, Giannitsis E, Darius H, Baldus S, Hamm C, Hambrecht R, Hofmeister HM, Katus H, Perings S, Senges J, Münzel T.

Clin Res Cardiol. 2015 Jul 7. [Epub ahead of print]

PMID:
26150114
2.

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.

Brambatti M, Darius H, Oldgren J, Clemens A, Noack HH, Brueckmann M, Yusuf S, Wallentin L, Ezekowitz MD, Connolly SJ, Healey JS.

Int J Cardiol. 2015 Oct 1;196:127-31. doi: 10.1016/j.ijcard.2015.05.141. Epub 2015 May 28.

PMID:
26093161
3.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

4.

Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry.

Härle T, Zeymer U, Hochadel M, Schmidt K, Zahn R, Darius H, Behrens S, Lauer B, Mudra H, Schächinger V, Elsässer A.

Clin Res Cardiol. 2015 Mar 25. [Epub ahead of print]

PMID:
25805412
5.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2015 Jun 2;313(21):2185.

6.

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.

De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators).

Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.

PMID:
25602175
7.

The German CPU Registry: Dyspnea independently predicts negative short-term outcome in patients admitted to German Chest Pain Units.

Hellenkamp K, Darius H, Giannitsis E, Erbel R, Haude M, Hamm C, Hasenfuss G, Heusch G, Mudra H, Münzel T, Schmitt C, Schumacher B, Senges J, Voigtländer T, Maier LS.

Int J Cardiol. 2015 Feb 15;181:88-95. doi: 10.1016/j.ijcard.2014.11.199. Epub 2014 Nov 28.

PMID:
25497526
8.

Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.

Breuckmann F, Hochadel M, Darius H, Giannitsis E, Münzel T, Maier LS, Schmitt C, Schumacher B, Heusch G, Voigtländer T, Mudra H, Senges J.

J Cardiol. 2015 Aug;66(2):108-13. doi: 10.1016/j.jjcc.2014.11.003. Epub 2014 Dec 12.

PMID:
25497278
9.

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.

De Caterina R, Ammentorp B, Darius H, Le Heuzey JY, Renda G, Schilling RJ, Schliephacke T, Reimitz PE, Schmitt J, Schober C, Zamorano JL, Kirchhof P; PREFER in AF Registry Investigators.

Heart. 2014 Oct;100(20):1625-35. doi: 10.1136/heartjnl-2014-305486. Epub 2014 Aug 8.

PMID:
25106421
10.

Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX).

Vincent JL, Privalle CT, Singer M, Lorente JA, Boehm E, Meier-Hellmann A, Darius H, Ferrer R, Sirvent JM, Marx G, DeAngelo J.

Crit Care Med. 2015 Jan;43(1):57-64. doi: 10.1097/CCM.0000000000000554.

PMID:
25083980
11.

[New direct oral oral anticoagulants (DOACs) - indications of DOACs].

Darius H.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 Mar;49(3):182-90; quiz 191. doi: 10.1055/s-0034-1372233. Epub 2014 Apr 7. German.

PMID:
24711238
12.

Ciguatera fish toxicity in French Polynesia: size does not always matter.

Gaboriau M, Ponton D, Darius HT, Chinain M.

Toxicon. 2014 Jun;84:41-50. doi: 10.1016/j.toxicon.2014.03.006. Epub 2014 Apr 1.

PMID:
24699216
13.

Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.

Le Heuzey JY, Ammentorp B, Darius H, De Caterina R, Schilling RJ, Schmitt J, Zamorano JL, Kirchhof P.

Thromb Haemost. 2014 May 5;111(5):833-41. doi: 10.1160/TH13-12-1007. Epub 2014 Mar 20.

PMID:
24651882
14.

[Antithrombotic treatment in acute coronary syndrome].

Darius H, Rupprecht HJ, Genth-Zotz S, Wittlinger T, Zotz R.

Dtsch Med Wochenschr. 2014 Jan;139 Suppl 1:S17-22. doi: 10.1055/s-0033-1359997. Epub 2014 Jan 20. Review. German. No abstract available.

PMID:
24446037
15.

Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry.

Härle T, Zeymer U, Schwarz AK, Lüers C, Hochadel M, Darius H, Kasper W, Hauptmann KE, Andresen D, Elsässer A.

Clin Res Cardiol. 2014 May;103(5):373-80. doi: 10.1007/s00392-014-0664-8. Epub 2014 Jan 17.

PMID:
24435358
16.

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).

Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL.

Europace. 2014 Jan;16(1):6-14. doi: 10.1093/europace/eut263. Epub 2013 Oct 1.

17.

Independent predictors of bleeding complications in patients undergoing PCI with concomitant treatment with bivalirudin in clinical practice results from the ImproveR registry.

Koeth O, Gulba D, Huber K, Madsen JK, Darius H, Schneider S, Zeymer U; ImproveR investigator group.

J Cardiovasc Pharmacol. 2013 Dec;62(6):507-11. doi: 10.1097/FJC.0000000000000005.

PMID:
24072173
18.

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.

Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.

Circulation. 2013 Jul 16;128(3):237-43. doi: 10.1161/CIRCULATIONAHA.112.001139. Epub 2013 Jun 14.

19.

[Stroke prevention in atrial fibrillation : old and new anticoagulants].

Darius H, Sommer S.

Herz. 2013 May;38(3):231-8. doi: 10.1007/s00059-013-3792-4. German. Erratum in: Herz. 2013 Aug;38(5):529-30.

PMID:
23632424
20.

The German CPU Registry: comparison of troponin positive to troponin negative patients.

Maier LS, Darius H, Giannitsis E, Erbel R, Haude M, Hamm C, Hasenfuss G, Heusch G, Mudra H, Münzel T, Schmitt C, Schumacher B, Senges J, Voigtländer T, Schüttert JB.

Int J Cardiol. 2013 Sep 30;168(2):1651-3. doi: 10.1016/j.ijcard.2013.03.009. Epub 2013 Apr 1. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk